These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Can systemic changes in the blood coagulation system be detected in low-dose local thrombolysis with r-tPA?]. Weichenhain B; Stiegler H; Spengel F; Standl E; Woitinas F; Roth R; Schulz K; Mehnert H Vasa Suppl; 1991; 32():314-7. PubMed ID: 1771523 [No Abstract] [Full Text] [Related]
15. Contrast extravasation from a Pulse-Tec graft: a complication of high-dose recombinant tissue-type plasminogen activator therapy. Buckenham TM; Taylor RS; Reiff D; Page JE Br J Radiol; 1992 Jun; 65(774):545-7. PubMed ID: 1628190 [No Abstract] [Full Text] [Related]
16. [Cholesterol crystal embolisms due to systemic thrombolysis of an acute myocardial infarct]. Diethelm A; Vorburger C; Anabitarte M; Haag E Schweiz Med Wochenschr; 1994 Aug; 124(33):1437-41. PubMed ID: 7939511 [TBL] [Abstract][Full Text] [Related]
18. Life-threatening anaphylactoid shock caused by recombinant tissue plasminogen activator. Wang CT; Lin FC; Khor GT; Chen CH; Huang P Am J Emerg Med; 2012 Jan; 30(1):253.e1-2. PubMed ID: 21109385 [TBL] [Abstract][Full Text] [Related]
19. [Effectiveness and tolerance of rt-Pa for local lytic therapy of 53 embolic and thrombotic occlusions of the lower extremity]. Spengel FA; Küffer G; Hufen V; Stiegler H Vasa Suppl; 1991; 33():127. PubMed ID: 1788642 [No Abstract] [Full Text] [Related]